Developmental Pathway Funding Scheme: Invited Stage Two
Funds academic-led translational research to develop novel therapeutics, devices, diagnostics, or interventions from early development to early-phase clinical studies.
Funder: UK Research and Innovation
Due Dates: July 8, 2026 (full application deadline)
Funding Amounts: No set limit; typically funds 80% of full economic cost. Total fund for this round: £26,000,000.
Summary: Supports invited stage two, academically-led translational projects to develop and test novel therapeutics, medical devices, diagnostics, and health interventions from early development through early-phase clinical studies.
Key Information: Only invited applicants from successful stage one proposals may apply.
Description
This opportunity funds invited stage two applications under the Developmental Pathway Funding Scheme, managed by the Medical Research Council (MRC) through UK Research and Innovation (UKRI). The scheme is designed to support academically-led translational research projects that advance novel therapeutics, medical devices, diagnostics, and other interventions, spanning the full developmental pathway—from early development and pre-clinical testing to early-phase clinical studies (up to phase 2a). The primary aim is to improve prevention, diagnosis, prognosis, or treatment of significant health needs, or to develop tools that accelerate intervention development. Projects must be academic-led but can involve industry or charity partners where this adds value.
